Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series

• Bilgin Osmanodja,
• Aylin Akifova,
• Klemens Budde,
• Michael Oellerich,
• Julia Beck,
• Kirsten Bornemann-Kolatzki,
• Ekkehard Schütz,
• Joachim Velden,
• Claudia Lehmann,
• Bastian Malte Krüger,
• Anette Bachmann,
• Jan Kowald

Affiliations

Bilgin Osmanodja

Department of Nephrology and Intensive Care, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany

Aylin Akifova

Department of Nephrology and Intensive Care, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany

Klemens Budde

Department of Nephrology and Intensive Care, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany

Michael Oellerich

Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany

Julia Beck

Chronix Biomedical GmbH, Göttingen, Germany

Kirsten Bornemann-Kolatzki

Chronix Biomedical GmbH, Göttingen, Germany

Ekkehard Schütz

Chronix Biomedical GmbH, Göttingen, Germany

Joachim Velden

Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

Claudia Lehmann

Institute for Transfusion Medicine, Laboratory for Transplantation Immunology, University Hospital Leipzig, Leipzig, Germany

Bastian Malte Krüger

Medical Department III, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany

Anette Bachmann

Medical Department III, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany

Jan Kowald

Medical Department III, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany